CN116096329A - Apparatus and method for restoring health by energy fields - Google Patents
Apparatus and method for restoring health by energy fields Download PDFInfo
- Publication number
- CN116096329A CN116096329A CN202080055246.2A CN202080055246A CN116096329A CN 116096329 A CN116096329 A CN 116096329A CN 202080055246 A CN202080055246 A CN 202080055246A CN 116096329 A CN116096329 A CN 116096329A
- Authority
- CN
- China
- Prior art keywords
- patient
- enclosure
- baffle
- glass tube
- energy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 9
- 230000036541 health Effects 0.000 title description 4
- 239000011521 glass Substances 0.000 claims abstract description 13
- 239000002985 plastic film Substances 0.000 claims abstract description 6
- 239000002759 woven fabric Substances 0.000 claims abstract description 5
- 239000002184 metal Substances 0.000 claims abstract description 4
- 229910052751 metal Inorganic materials 0.000 claims abstract description 4
- 230000002996 emotional effect Effects 0.000 claims abstract description 3
- 230000035876 healing Effects 0.000 claims description 3
- 239000002105 nanoparticle Substances 0.000 claims description 3
- 238000011084 recovery Methods 0.000 claims description 2
- 238000009223 counseling Methods 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 238000012800 visualization Methods 0.000 claims 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract description 3
- 229910052802 copper Inorganic materials 0.000 abstract description 3
- 239000010949 copper Substances 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 2
- 230000033001 locomotion Effects 0.000 description 12
- 210000002216 heart Anatomy 0.000 description 11
- 210000000056 organ Anatomy 0.000 description 11
- 230000008602 contraction Effects 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 3
- 238000001467 acupuncture Methods 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000019695 Migraine disease Diseases 0.000 description 2
- 208000008558 Osteophyte Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000005672 electromagnetic field Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 206010027599 migraine Diseases 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- JAPJOLBDXOXSKE-WQICJITCSA-N (2s)-2-[[(2s)-2-[[(e)-3-(furan-2-yl)prop-2-enoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)\C=C\C=1OC=CC=1)C1=CC=CC=C1 JAPJOLBDXOXSKE-WQICJITCSA-N 0.000 description 1
- 102400000748 Beta-endorphin Human genes 0.000 description 1
- 101800005049 Beta-endorphin Proteins 0.000 description 1
- 102100025841 Cholecystokinin Human genes 0.000 description 1
- 101800001982 Cholecystokinin Proteins 0.000 description 1
- 102400000739 Corticotropin Human genes 0.000 description 1
- 101800000414 Corticotropin Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- YFGBQHOOROIVKG-FKBYEOEOSA-N Met-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 YFGBQHOOROIVKG-FKBYEOEOSA-N 0.000 description 1
- 108010042237 Methionine Enkephalin Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 102100037505 Secretin Human genes 0.000 description 1
- 108010086019 Secretin Proteins 0.000 description 1
- 208000000491 Tendinopathy Diseases 0.000 description 1
- 206010043255 Tendonitis Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WOPZMFQRCBYPJU-NTXHZHDSSA-N beta-endorphin Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C1=CC=CC=C1 WOPZMFQRCBYPJU-NTXHZHDSSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940107137 cholecystokinin Drugs 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 229960000258 corticotropin Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
- 210000002064 heart cell Anatomy 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002297 mitogenic effect Effects 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 229960002101 secretin Drugs 0.000 description 1
- OWMZNFCDEHGFEP-NFBCVYDUSA-N secretin human Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(N)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)C1=CC=CC=C1 OWMZNFCDEHGFEP-NFBCVYDUSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 201000004415 tendinitis Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/16—Screening or neutralising undesirable influences from or using, atmospheric or terrestrial radiation or fields
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M21/02—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
- A61M2021/0005—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
- A61M2021/0055—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus with electric or electro-magnetic fields
Abstract
An apparatus for providing an energy field to promote a self-healing process of a body, the apparatus comprising electronics immersed in a dielectric oil in a first enclosure that accelerate and rotate an energy current within an inflatable glass tube. The tube extends through a small opening into a larger second patient enclosure lined with metal (e.g., copper) so that energy emitted from the tube is directed toward a concave baffle covered with a dense woven fabric. The plastic sheet optionally protects the patient from arcing with the baffle. The chair/support is provided for proper positioning of the patient, as well as for positioning of the patient and providing psychological and emotional guidance to the practitioner/therapist's chair to optimize patient acceptance of the treatment.
Description
Cross Reference to Related Applications
The present application claims priority from provisional application 62/921,078 filed on 5/30 of 2019, the entire contents of which are incorporated herein by reference.
Background
Technical Field
In general, the present invention relates to an apparatus and method designed to assist a patient's body in self-healing.
Description of related Art and invention scope
According to the lorentz interpretation, octagons and straight line reciprocal couplings in space produce non-zero masses and spin-1, from extrapolation from non-zero space, templates of the earth's cavity and transverse lightning shock waves are formed. The consequences of non-zero positive mass are discussed.
Drawings
Figure 1 depicts lightning.
Fig. 2 depicts an apparatus for focusing harmonic energy from four independent series resonant circuits.
Fig. 3 depicts the propagation of the hypersonic speed of the coulomb field of a miniature amplified emitter of the propagation of the hypersonic energy, shown in the coulomb current detected by the same antenna system.
Fig. 4 depicts a miniature amplified emission instrument treatment room. Electromagnetic shock waves in a controlled nonlinear environment produce a phase conjugate (time-reversed) copy that resonates with a human electromagnetic field (human air field). The use of mitogenic entropy reduction in the body is both medical and scientific.
Fig. 5 is a schematic drawing drawn in a negative ion generator room, reflecting the meridians and acupoints, ear and nose acupoints of the heart, triple energizer, conception vessel (chest) of traditional Chinese medicine. Fig. 6 depicts the synchronization of brain waves during meditation.
Fig. 7 depicts a graph of oxygen consumption during a sitting Buddhist and sleep.
Fig. 8 depicts blood lactic acid changes associated with a sitting Buddhist.
Fig. 9 shows contraction and expansion of the acupuncture region.
Fig. 10 depicts the lateral quanta of energy ingress and movement in multiple directions.
Fig. 11 (fig. 11A-11G) depicts various internal and external exercises.
Fig. 12 depicts internal and external features of the treatment device.
Fig. 13 depicts an oscilloscope image of a measurement of light velocity from an on-axis sensor within a miniature amplification transmitter in 2004. This shows the speed of superlight and thus the change in speed.
Description of the invention
An apparatus and method designed to assist a patient in self-healing.
The patient is placed in a metal (e.g., copper) lined enclosure (essentially a faraday cage) and placed in a comfortable and/or therapeutically beneficial position, sitting, reclining, standing or otherwise.
Optimally, the patient enclosure is maintained at or near 90 degrees Fahrenheit and the relative humidity is at or near 85%.
A transformer and coil immersed in insulating oil in a separate enclosure outside the patient enclosure accelerates and rotates the energy current to produce a high voltage, rapidly modulated current in an inflated glass tube, one end of which extends into the patient enclosure through an opening. The energy emitted from the tube is directed to a dome or circular concave baffle covered with a tightly woven fabric, which disperses the energy field within the enclosure.
A plastic sheet optionally with embedded nanoparticles is optionally placed between the dome and the patient to eliminate potential arcing between the dome and the patient.
Thus, the energy field generated in the room contributes to the natural energy characteristics (e.g., gas) of the patient himself to promote the recovery of health and equilibrium.
The body is encouraged to achieve self-healing (i.e., restore an appropriately balanced and free-flowing state of energy) by immersion in this field.
Optionally, a chair is provided for a medical practitioner/therapist to accompany the patient during treatment to properly align the patient with the device. And also provides psychological and emotional guidance to the patient to promote optimal acceptance of the benefit by the patient.
FIG. 12 depicts a preferred embodiment of the present invention, comprising: element 1200, which is an enclosure for a therapeutic device, has walls, a floor, and a ceiling that are composed of a layer of metal (e.g., copper) and a layer of insulating material; element 1201 is a housing filled with dielectric oil for an electrical circuit; element 1202, a glass inflator; element 1203 is a tightly woven fabric wrapped dome having a diameter of about 18 inches; element 1204, an opening for cartridge 1202 to enter enclosure 1200 from housing 1201 through the enclosure wall; element 1205, a removable plastic screen, separates the disc from the treatment area of the enclosure; elements 1206, 1207 and 1208, respectively benches, chairs and stools, any of which may be placed in an enclosure to enable the proper positioning of a particular area of a patient to be treated with respect to the treatment field generated; element 1209, an optional seat for a person administering treatment to a patient; and element 1210 is a sliding door that allows access to the enclosure.
Theoretical basis and technical details of the invention
The following are technical details, as well as a discussion of scientific theory supporting the invention and a discussion of clinical findings.
Results of non-zero positive mass
If the mass is small enough, this means transverse (spin J 3 = ±1) and longitudinal (J 3 =0) actual (FAPP) separation of max Wei Bo. The former (J) 3 = ±1) is at a speed of<c transverse wave of movement, the latter corresponding to static coulomb field exp (-muR μ)/rμ, rμ representing the distance of the charge center xμ from the center point in the stationary coordinate system.
a) The guiding field surrounds the particle-like photons in the following way: its internal orbital motion is about an axis defined by its charge orbital momentum.
b) In its stationary coordinate system (centered at xμ), the longitudinal photon is static (i.e., Δxμ=γ 2 X μ), and its charge distribution is flat along X μ in any other lorentz coordinate system according to the law of narrow relativity.
c) Photons exist only in transverse electromagnetic waves, and their energy momentum is carried by the photons and waves.
d) This also means that the mobile, limited source contains electrons: 1) Surrounded by a true, physical, finite coulomb-type field (the coulomb-type field corresponds to all J' s 3 Superposition of coulomb transverse electric field of =0 in its stationary coordinate system. The field (a) contains no photons and is around the sourceExpansion limited) 2) will emit longitudinal waves (J) from its accelerating motion 3 =0)。
Extended electrons (or positrons) are also contained in dirac-type ethernets. The electrons are extended by passing through the centroid yμ (where e=hv=mc 2 ) And a locally extended subelement defined by different charge centers Y mu about which the electron charge distribution rotates. This center rotates around Y [ mu ] with Compton distance and the speed is equal to C. The electromagnetic charge rotates itself with angular momentum h/2.
In this model, the electrons are extended double localized structures (consisting of one hole and one bump in dirac ethernet) containing different angular momentums around Y μ and X μ, the latter surrounded by a rotating charge and mass distribution.
Local photons and electronic elements are embedded in the ethernet, which moves in planar space. Ethernet locally satisfies the narrow relativity law (including measuring instruments), but its motion of accelerating elements does not satisfy the generalized relativity law and changes its shape upon accelerating motion (detected by a real local ethernet building element) in a flat space of its movement.
Fig. 3 demonstrates the superlight velocity propagation of the coulomb field of a micro-amplifying transmitter for superlight velocity energy propagation, shown in coulomb currents detected by the same antenna system. The distance of the effect antenna from the dome 4.25' (lower trace) should produce a speed of light delay of 4.25 ns. However, the observed causal coincidence of ground currents at the dome indicates the speed of superlight. The peak of the supersonic speed is followed by a lower rate. Variation of light speed. Fig. 13 constitutes another measurement, with a slightly different oscilloscope setup.
The enlarged emitter forms water, establishes acupoint emission, and improves disease condition.
The negative ion wind generated by the amplification emitter is generated by a series of LEM solitons that counteract the entropy heat generated by the vapor jet, which keeps the elliptical terminal moist. The ability of the structured negative ion wind to form atmospheric moisture plays an important role in the physical health of the body. During a single treatment, the average person would cut off one-eighth to three-fourths pounds of toxic sweat, while the well-watered person would cut off 2 pounds. Several extremely dehydrated humans, most notably, weigh an increase of 2 pounds.
Fig. 5 is a sketch of the present inventors drawn in the anion generator room reflecting the heart, triple energizer, conception vessel (chest) meridians and acupoints, ear and nose acupoints of traditional Chinese medicine. The open circuit produces changes in the illumination of the acupoints and the radiated violet light. In complete darkness, it can be seen that this equilibrium interaction activates the various acupoints on the skin surface. Individuals in contact with the instrument will emit white light from their digits and grasp that the acupoints of the whole body show approximate patterns, such as trifocal (the rear of the forearm) or the heart access points on the elbow and arm sides. See fig. 5. For torso changes, it appears in one example to have small dots throughout the torso, while in another patient approximates the yoga wheels of indian. The healing beam moves back and forth, and is guided by electromagnetic interaction of the body and the nanosecond periodic Tesla wave and negative ion wind generated by the electromagnetic interaction. The instructions of instruments are not needed for injuries, bone spurs, cancer tumors and diseased organs, and positive ions in the body are bombarded by negative ions in the ultraviolet light changing beam. "molecules interact without having to touch each other. Energy may flow through electromagnetic field …, which together with water forms a living matrix. The water may form a structure that transmits energy. "
Improvements in tendinitis, ligaments, superficial wounds, bone spurs, oedema, osteoarthritis, sinusitis, migraine and various cancers were noted. {xiv}{xv}{xvi} A subject treated for an organ (e.g., skin or heart) will immediately alleviate, but not last long. Subsequent clinical examinations find other organ problems, such as the stomach or colon, which affect other diseased organ areas. This organ interaction and imbalance will be discussed later, but this is an important understanding. Boss-Einstein condensation of inorganic and organic substances (human Global physiological measurement)
The curves and lateral phenomena can be seen in the structure of the human skull, as well as the up-down lateral directions of the nervous (motor) system, the immune system, blood (oxygenated and deoxygenated), and the ingress and egress of cell and lung respiration. Organs and hearts may become unsynchronized due to cultural and individual differences and habits of food and substance intake.
Duality is a shrinking process. Clinical experience regards patients (e.g. migraine) as a contraction of a round head. When energy is added, the contraction will decrease and the expansion will open, providing more space and relaxation ability. Acupuncture does this by vertical insertion, mechanical manual pressure, qigong (not touching the body), laser or movement, even heat. More careful examination showed that in the opposite case of stimulation, the biochemical shrinkage became a biochemical relaxation response. {xxii}{xxiii} Acetylcholine, serotonin, methionine-enkephalin, beta-endorphin, corticotropin, secretin, cholecystokinin, norepinephrine and GABA are found at all points and along the meridians, regardless of the meridian. Extensive biochemical changes occur immediately throughout the body. High power lights on the nails showed that small capillaries immediately developed vasodilation. The area above the acupoint experiences six periods of sustained contraction and expansion per second. In addition, toxic conditions of the organ alter the organ pathways. The heart and diaphragm have multiple phases, and pathology occurs when one phase seizes or contracts. In the heart, the ribcage locks, in the diaphragm, and the posterior cervical torsion. Fig. 9 shows contraction and expansion of the acupuncture region. Fig. 10 illustrates the lateral quanta of energy ingress and movement in multiple directions.
These dome regions bulge around the body surface. The domes are located in a field external to the body. The dome is covered by a blue canopy with a hexagonal structure lining, with a space-density matrix U-gas region inside and the other half penetrating the inside. The energy quanta move laterally or rotate up or down the dome.
This understanding comes from 300 clinical cases of different diseases over five years and these thought images were generated from this long-term clinical study. It is certain that the organ is solid (liver, kidney, pancreas, heart) or hollow (gall bladder, stomach, lung, large intestine and small intestine), the hollow organ having lateral movement, such as bile, water, food and digestive food. Solid organs filter substances, and the heart and its electrical heart cells produce rhythms for arterial contraction and circulating blood. The heart has more than one direction, up to the head and down to the body. The anoxic blood moves against gravity back through the veins to the heart and lungs, depending on the body movement. Veins have a shutter to prevent reflux, but require movement to overcome gravity.
Claims (11)
1. A device for generating an energy field to promote energy healing, comprising:
a. a first enclosure housing electrical components further including at least a transformer and a coil immersed in a dielectric oil;
b. an air-filled glass tube through which an energy current accelerating the modulation is induced at a first end under the action of the electrical components of element a;
c. a metal-lined second enclosure that is large enough to house a subject and optionally a therapist/practitioner;
d. an opening in the second enclosure through which the second end of the gas-filled glass tube enters the second enclosure;
e. an optional seat/support member for positioning the patient relative to the energy current and field.
2. The apparatus of claim 1, further comprising:
f. a baffle positioned between the second end of the gas-filled glass tube and the patient to disperse the acceleratively modulated energy current exiting from the second end of the gas-filled glass tube.
3. The apparatus of claim 2, further comprising:
g. the baffle is generally circular.
4. The apparatus of claim 3, further comprising:
h. the baffle is further recessed and oriented such that the second end of the gas-filled glass tube is directed toward the recess.
5. The apparatus of claim 4, further comprising:
i. the baffle is further covered with a tightly woven fabric.
6. The apparatus of claim 2, further comprising:
j. a plastic sheet positioned between the baffle and the patient to prevent arcing between the baffle or tube and the patient.
7. The apparatus of claim 6, further comprising:
k. the plastic sheet is impregnated with nanoparticles.
8. The apparatus of claim 2, further comprising:
the atmosphere within the metal-lined second enclosure is maintained at a temperature of approximately 90 degrees Fahrenheit and a humidity of approximately 85%.
9. A method of promoting energy recovery comprising:
a. the patient is placed in a metal lined enclosure of a device comprising.
i. A first enclosure housing the electrical components, further comprising at least a transformer and a coil immersed in a dielectric oil;
a gas-filled glass tube through which an energy current of accelerating modulation is induced at a first end under the action of the electrical components of element a;
a metal-lined second enclosure sufficiently large to house a subject and optionally a therapist/medical practitioner;
an opening in the second enclosure through which the second end of the gas-filled glass tube enters the second enclosure;
an optional seat/support member for positioning the patient with respect to the energy current and field.
A generally circular concave baffle positioned between the second end of the gas-filled glass tube and the patient to disperse the accelerated modulated energy current exiting from the second end of the gas-filled glass tube, the concave baffle oriented such that the second end of the gas-filled glass tube is directed toward the recess, and the baffle further covered with a tightly woven fabric.
A plastic sheet impregnated with nanoparticles, the plastic sheet being positioned between the baffle and the patient to prevent arcing between the baffle or tube and the patient.
b. The atmosphere within the metal-lined second enclosure is maintained at a temperature of approximately 90 degrees Fahrenheit and a humidity of approximately 85%.
10. The method of claim 9, further comprising:
c. the patient is positioned relative to the energy current and field to optimally promote energy healing.
11. The method of claim 10, further comprising:
d. the patient is instructed/instructed by the therapist/practitioner to perform psychological and/or emotional exercises including, but not limited to, counseling, meditation and visualization.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962921070P | 2019-05-30 | 2019-05-30 | |
US62/921,070 | 2019-05-30 | ||
PCT/US2020/035469 WO2020243677A1 (en) | 2019-05-30 | 2020-05-30 | Apparatus and method for restoring heath via energetic field |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116096329A true CN116096329A (en) | 2023-05-09 |
Family
ID=73552431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202080055246.2A Pending CN116096329A (en) | 2019-05-30 | 2020-05-30 | Apparatus and method for restoring health by energy fields |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP3976173A4 (en) |
JP (1) | JP2022535232A (en) |
KR (1) | KR20220016175A (en) |
CN (1) | CN116096329A (en) |
AU (1) | AU2020283059A1 (en) |
CA (1) | CA3142422A1 (en) |
IL (1) | IL288540A (en) |
MX (1) | MX2021014556A (en) |
WO (1) | WO2020243677A1 (en) |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040210289A1 (en) * | 2002-03-04 | 2004-10-21 | Xingwu Wang | Novel nanomagnetic particles |
US20050249667A1 (en) * | 2004-03-24 | 2005-11-10 | Tuszynski Jack A | Process for treating a biological organism |
ATE454922T1 (en) | 2005-04-21 | 2010-01-15 | Ksm Inc | ELECTROMAGNETIC TREATMENT DEVICE |
US7479101B2 (en) * | 2005-04-21 | 2009-01-20 | Ksm, Inc. | Method for treating an animal using a constant amplitude electromagnetic field |
US9089719B2 (en) * | 2009-03-20 | 2015-07-28 | ElectroCore, LLC | Non-invasive methods and devices for inducing euphoria in a patient and their therapeutic application |
US8188688B2 (en) * | 2008-05-22 | 2012-05-29 | Vladimir Balakin | Magnetic field control method and apparatus used in conjunction with a charged particle cancer therapy system |
US8968173B2 (en) * | 2008-07-16 | 2015-03-03 | Frank Sivo | Methods to arrest cancer cell growth and proliferation using electromagnetic energy delivered via electromagnetic coil systems |
US9427505B2 (en) * | 2012-05-15 | 2016-08-30 | Smith & Nephew Plc | Negative pressure wound therapy apparatus |
US20140343642A1 (en) | 2013-05-14 | 2014-11-20 | Vincent Lauer | Device for treating diseases |
US10589086B2 (en) | 2014-10-03 | 2020-03-17 | Nervive, Inc | Deep nerve stimulator |
-
2020
- 2020-05-30 KR KR1020217042952A patent/KR20220016175A/en unknown
- 2020-05-30 MX MX2021014556A patent/MX2021014556A/en unknown
- 2020-05-30 AU AU2020283059A patent/AU2020283059A1/en active Pending
- 2020-05-30 EP EP20815374.2A patent/EP3976173A4/en active Pending
- 2020-05-30 CN CN202080055246.2A patent/CN116096329A/en active Pending
- 2020-05-30 WO PCT/US2020/035469 patent/WO2020243677A1/en unknown
- 2020-05-30 JP JP2021571350A patent/JP2022535232A/en active Pending
- 2020-05-30 CA CA3142422A patent/CA3142422A1/en active Pending
-
2021
- 2021-11-30 IL IL288540A patent/IL288540A/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP2022535232A (en) | 2022-08-05 |
KR20220016175A (en) | 2022-02-08 |
WO2020243677A1 (en) | 2020-12-03 |
WO2020243677A9 (en) | 2021-01-28 |
MX2021014556A (en) | 2022-04-06 |
CA3142422A1 (en) | 2020-12-03 |
AU2020283059A1 (en) | 2022-01-27 |
EP3976173A4 (en) | 2023-06-14 |
EP3976173A1 (en) | 2022-04-06 |
IL288540A (en) | 2022-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Rosch | Bioelectromagnetic and subtle energy medicine: the interface between mind and matter | |
Becker | Six pillars of energy medicine: Clinical strengths of a complementary paradigm | |
Zhou et al. | Bioelectrodynamics in living organisms | |
Omura et al. | Unique changes found on the qi gong (chi gong) master’s and patient’s body during qi gong treatment: Their relationships to certain meridians & acupuncture points and the re-creation of therapeutic qi gong states by children & adults | |
CN116096329A (en) | Apparatus and method for restoring health by energy fields | |
WONG et al. | Acupuncture: from needle to laser | |
RU2621547C2 (en) | Method for remote electromagnetic multiwave radio neuroengineering of human brain | |
US9821168B2 (en) | Medical bioelectric plasma beam | |
US11771894B2 (en) | Apparatus and method for restoring health via energetic field | |
Wang | The Theory of Chee that Transformed Traditional Chinese Medicine (TCM) into Scientific TCM | |
Raines | Electromagnetic field interactions with the human body: Observed effects and theories | |
EP0597702B1 (en) | Curative device | |
CN205163931U (en) | Physiotherapy equipment is synthesized to intelligent magnetism, electricity, light | |
Waechter | Qi and bioelectromagnetic energy | |
Shinnick | DUAL PROPERTIES OF ELECTROMAGNETIC LIGHT: THE CURVILINEAR (OCTAGONAL) AND RECTILINEAR IN THE COSMOS, EARTH AND APPLICATIONS FOR MEDICINE AND DISEASE | |
US20220401748A1 (en) | Cold air plasma generating apparatus | |
Parke et al. | Electric and magnetic fields in life | |
Aronowitz | Ethereal fire: antecedents of radiology and radiotherapy | |
CN1025775C (en) | Thermal-electric-magnetic cupping jar therapy instrument | |
Bogomolov et al. | Therapeutic medical equipment | |
Shinnick et al. | Whole Person Healing: The O-Ring Imaging Technique Influences to Oriental and Occidental Medicine | |
Turrell | The principles of electrotherapy and their practical application | |
Ye et al. | Thermal tomography imaging in photonic traditional Chinese medicine information therapy with holistic effect for health whole nursing | |
CN1084095A (en) | Method and equipment series with circulation operation energy physiotherapy | |
Smith | Qi and the frequencies of bioelectricity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40093017 Country of ref document: HK |